Please login to the form below

Not currently logged in
Email:
Password:

Dr Reddy’s Laboratories founder passes away

Dr K. Anji Reddy loses cancer battle

Dr Reddy's Laboratories Dr K Anji ReddyDr K Anji Reddy, the founder and chairman of India's Dr Reddy's Laboratories died last week after a long battle with liver cancer.

The son of a turmeric farmer, he set up the company that bears his name in 1984 and grew the Hyderabad-based firm into one of India's leading pharmaceutical companies.

In 1993, it became the first initiate domestic firm to begin its own basic drug discovery research and, while this has yet to come to fruition, its generics business has gone from strength to strength.

His son, and current managing director of Dr Reddy's Laboratories, Satish Reddy said: “Dr Reddy touched millions of lives through his contribution to the pharmaceutical industry and his philanthropic efforts. In improving access to affordable, high quality medicines and in innovation, his contributions have been extraordinary.”

Dr K Anji Reddy was increasingly focused on philanthropy in the last 15 years, leading initiatives to provide safe rural drinking water and meals to school children and farmers.

Of late, the company has been run by his son K Satish Reddy, as managing director and COO, and his son-in-law G V Prasad, who is the vice chairman and CEO.

A BSc graduate from Bombay University with specialisation in Pharmaceutical Science and Fine Chemicals, Dr Reddy obtained his PhD in Chemical Engineering from National Chemical Laboratory, Pune.

Soon after his studies, he served in the state-owned IDPL before he founded his own company in 1984.

Dr Reddy served as a member of the Prime Minister's Council on Trade & Industry, Government of India and was honoured with one of India's highest civilian awards, the Padma Bhushan, in April 2011.

18th March 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics